MYCOBUTIN
Identification of Mycobutin
| No description |
Google image searchProduct monograph
Active ingredient
rifabutin, 150 MG
DIN: 02063786
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 16-FEB-2005
ATC:
- J04 — ANTIMYCOBACTERIALS (ATC, ATC/DDD, )
- J04A — DRUGS FOR TREATMENT OF TUBERCULOSIS (ATC, ATC/DDD)
- J04AB — Antibiotics (ATC, ATC/DDD)
- J04AB04 — RIFABUTIN (ATC/DDD)
Reference brand drug: Mycobutin
Pharmaceutical standard: MFR
